Cannabinoids and Schizophrenia: Risks and Therapeutic Potential

Abstract

A convergence of evidence shows that use of Cannabis sativa is associated with increased risk of developing psychotic disorders, including schizophrenia, and earlier age at which psychotic symptoms first manifest. Cannabis exposure during adolescence is most strongly associated with the onset of psychosis amongst those who are particularly vulnerable, such… (More)
DOI: 10.1007/s13311-015-0382-6

Topics

  • Presentations referencing similar topics